×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
MediWound Ltd. (NASDAQ:MDWD) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The ...
Yahoo Finance
After the latest results, the four analysts covering MediWound are now predicting revenues of US$24.0m in 2024. If met, this would reflect a...
1 month ago
Mediwound optimistic about wound therapy EscharEx after Phase II VLU trial
Clinical Trials Arena
Mediwound optimistic about wound therapy EscharEx after Phase II VLU trial. The most recent data continues to support the pivotal trial of...
2 months ago
Revenues Tell The Story For MediWound Ltd. (NASDAQ:MDWD) As Its Stock Soars 25%
Simply Wall Street
MediWound Ltd. ( NASDAQ:MDWD ) shares have continued their recent momentum with a 25% gain in the last month alone...
5 days ago
Teva set to invest in MediWound: :: HBW Insight
HBW Insight
Israeli wound care company MediWound has attracted funding from several institutional, private and corporate investors including Teva Pharmaceutical...
5 days ago
StockNews.com Upgrades MediWound (NASDAQ:MDWD) to “Sell”
Defense World
Read StockNews.com Upgrades MediWound (NASDAQ:MDWD) to “Sell” at Defense World.
2 days ago
US Department of Defense funds MediWound's non-surgical burn treatment
biopharma-reporter.com
Biotherapeutics company MediWound has secured an additional $6.7 million in funding from the US Department of Defense to advance its...
4 months ago
DoD Grants Additional Funds to MediWound for Advancement of Non-Surgical Treatment for Field Care Burns
PharmTech
MediWound has been granted an additional $6.7 million by the DoD to advance NexoBrid as a non-surgical field care solution for the US...
4 months ago
MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
Yahoo Finance
Oral presentations include additional comparative data between EscharEx® and SANTYL®, and new analyses show strong correlation between wound...
2 weeks ago
While institutions invested in MediWound Ltd. (NASDAQ:MDWD) benefited from last week's 16% gain, individual investors stood to gain the most
Simply Wall Street
Key Insights The considerable ownership by individual investors in MediWound indicates that they collectively have a...
2 weeks ago
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
Yahoo Finance
MediWound (MDWD) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate...
3 weeks ago